FGF-4 Activators
FGF-4 activators encompass a diverse group of chemicals that interact with various cellular signaling pathways, indirectly influencing FGF-4 activity. These activators do not directly bind or activate FGF-4 but instead modulate the cellular environment and signaling pathways that can lead to changes in FGF-4 activity. The primary mechanism of action for these chemicals is through the modulation of pathways like cAMP/PKA, Wnt/GSK-3β, histone deacetylation, retinoic acid signaling, EGFR signaling, and others. For instance, Forskolin, by enhancing cAMP levels, activates PKA, leading to a cascade of events that could upregulate FGF-4 activity. Similarly, agents like Sodium Butyrate and Retinoic Acid affect gene expression patterns that could have downstream effects on FGF-4 signaling pathways. The indirect modulation of FGF-4 activity through these diverse pathways highlights the intricate network of cellular signaling and its impact on specific growth factors.
In another aspect, chemicals like Curcumin and Sildenafil Citrate demonstrate the complex interplay between different signaling molecules and pathways in the cell. By influencing pathways like inflammation, cell growth, and cGMP signaling, these chemicals create an environment conducive to modifying FGF-4 activity. Rapamycin and LY294002 represent another class of indirect activators, targeting key regulatory molecules like mTOR and PI3K. Their action leads to alterations in cellular processes, which may impact FGF-4 signaling either through direct interaction with the pathway components or through broader cellular changes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP can enhance PKA (protein kinase A) activity, which may influence the FGF pathway by modulating cellular responses, thereby indirectly affecting FGF-4 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). PKC plays a role in several signaling pathways and could modify the intracellular environment in a way that indirectly promotes FGF-4 activity through cross-talk with other signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, a component of the Wnt signaling pathway. While Wnt signaling is distinct from FGF signaling, cross-talk between these pathways may indirectly influence FGF-4 activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, affecting chromatin remodeling and gene expression. This alteration in gene expression could impact pathways associated with FGF-4, potentially modulating its activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid impacts gene expression through retinoic acid receptors. It can influence numerous signaling pathways, including those associated with FGF-4, thus potentially modulating its activity indirectly. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, mimics the action of cAMP and can thus enhance PKA activity. This may indirectly affect FGF-4 activity by altering the cellular signaling environment. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways, including those involved in inflammation and cell growth. Its broad spectrum of activity might indirectly affect FGF-4 signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and proliferation. By altering mTOR activity, it might indirectly influence pathways associated with FGF-4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K/Akt signaling is crucial in various cellular processes, and its inhibition could lead to alterations in pathways that indirectly modulate FGF-4 activity. | ||||||